Navigation Links
Unlocking the function of enzymes
Date:11/6/2007

COLLEGE STATION, Nov. 6, 2007 Fitting a key into a lock may seem like a simple task, but researchers at Texas A&M University are using a method that involves testing thousands of keys to unlock the functions of enzymes, and their findings could open the door for new targets for drug designs.

Texas A&M researcher Frank Raushel is part of a team of scientists who modified a technique called molecular docking to predict which molecule, called a substrate, triggers an enzyme into action, enabling them to decipher an enzymes function based on its structure alone.

The teams paper was published in the journal Nature.

Most biological processes depend on enzymes, which are proteins that speed up chemical reactions, but the function of many enzymes remains a mystery.

There are thousands of molecules that could be substrates [for a specific enzyme], and it would take too long to physically test them all, Raushel said. So we decided there was a need for a new method to determine the function of enzymes.

The team started with the three-dimensional X-ray structure of an enzyme and then used a computer to try to fit different smaller molecules into the active site of the enzyme like pieces in a puzzle.

Each enzyme has a specific size and shape, Raushel said, and you can use a computer to take small molecules and fit them into the active site of an enzyme one by one and score them on how well they fit. Its more or less like fitting a key into a lock, but a lot more difficult since both the enzyme and the substrate are conformationally flexible.

After the computer scores the molecules on how well they fit the enzyme, it ranks their order, and the researchers can then use the prioritized list to decide which molecules to physically test.

As far as we know, this is the first time anybody has used molecular docking to predict the function of an enzyme, Raushel said. And it was verified by both experiment and X-ray crystallography.

Other methods researchers use to try to determine an enzymes function or substrate specificity include physically testing thousands of possible molecules, gathering information from the nearby genes, and comparing the structure of the enzyme to that of other enzymes with known functions. I think that in the end, well have to use all of these methods together, Raushel said. One single method just wont suffice.

Raushel and his team plan to continue using their molecular docking method to find the function of other enzymes.

Were looking at other X-ray structures of proteins that have unknown functions, and were working to fill the gap, Raushel said. Were trying to see how general this method is going to be or if we were just lucky in this particular case.

Raushel and Texas A&M post-doctoral associate Ricardo Marti-Arbona work in conjunction with Brian Shoichet at the University of California, San Francisco, and Steven Almo from the Albert Einstein College of Medicine in New York.

Raushel hopes that over the next five years, the team can start to use its findings to locate potential targets for new drugs.

Understanding the substrate specificity of certain enzymes could allow researchers to differentiate enzymes that catalyze one reaction in pathogenic organisms and a slightly different reaction in human systems, Raushel said. This would allow scientists to design [drugs] that would specifically target a pathogenic organism while not affecting the human enzyme.


'/>"/>

Contact: Amelia Williamson
aaw11@tamu.edu
979-862-2694
Texas A&M University
Source:Eurekalert

Related biology news :

1. Geron Demonstrates hESC-derived cardiomyocytes improve heart function after myocardial infarction
2. Device helps patients survive, regain function til transplant
3. Specific brain protein required for nerve cell connections to form and function
4. Systems Biology poised to revolutionize the understanding of cell function and disease
5. Women more depressed and men more impulsive with reduced serotonin functioning
6. Researchers expand efforts to explore functional landscape of the human genome
7. The endocannabinoids: Functional roles and therapeutic opportunities
8. Elevated nitric oxide in blood is key to high altitude function for Tibetans
9. Children with gene show reduced cognitive function
10. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
11. MGH researchers describe new way to identify, evolve novel enzymes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology: